Literature DB >> 7714549

TM-1 cells from an established human malignant glioma cell line produce PDGF, TGF-alpha, and TGF-beta which cooperatively play a stimulatory role for an autocrine growth promotion.

M Kurimoto1, S Endo, K Arai, Y Horie, K Nogami, A Takaku.   

Abstract

We have previously established a human malignant glioma cell line, TM-1. TM-1 cells could proliferate in the serum-free medium. In the present study, immunochemical analysis demonstrated that platelet-derived growth factor (PDGF), transforming growth factor (TGF)-alpha, and TGF-beta are present in the serum-free medium conditioned by growing TM-1 cells. While the cells appeared to possess a single type of binding sites for epidermal growth factor (EGF) with properties comparable to those determined for other tumor cells, the conditioned medium did not contain EGF.PDGF, TGF-alpha, and EGF added exogenously to serum-free media stimulated thymidine incorporation into DNA of TM-1 cells. In addition, antibodies specific for PDGF and TGF-alpha suppressed this activity. These results indicate autocrine and stimulatory roles of PDGF and TGF-alpha for the proliferation of TM-1 cells. As observed for other tumor cells, TGF-beta by itself weakly suppressed thymidine incorporation by TM-1 cells. However, TGF-beta employed in combination with TGF-alpha or EGF appeared to stimulate thymidine incorporation, suggesting that a cooperative action of TGF-beta with different growth factors may be involved in the stimulatory growth regulation at least for TM-1 cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7714549     DOI: 10.1007/bf01058353

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  44 in total

1.  Expression of platelet-derived growth factor and transforming growth factor and their correlation with cellular morphology in glial tumors.

Authors:  T B Mapstone
Journal:  J Neurosurg       Date:  1991-09       Impact factor: 5.115

2.  Inhibition of lymphocyte function by glioblastoma-derived transforming growth factor beta 2.

Authors:  M C Kuppner; M F Hamou; Y Sawamura; S Bodmer; N de Tribolet
Journal:  J Neurosurg       Date:  1989-08       Impact factor: 5.115

3.  Growth factors from murine sarcoma virus-transformed cells.

Authors:  J E de Larco; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin.

Authors:  T A Libermann; H R Nusbaum; N Razon; R Kris; I Lax; H Soreq; N Whittle; M D Waterfield; A Ullrich; J Schlessinger
Journal:  Nature       Date:  1985 Jan 10-18       Impact factor: 49.962

6.  Transforming growth factor-alpha, epidermal growth factor receptor, and proliferating potential in benign and malignant gliomas.

Authors:  M Maruno; J S Kovach; P J Kelly; T Yanagihara
Journal:  J Neurosurg       Date:  1991-07       Impact factor: 5.115

7.  Interaction of acidic fibroblast growth factor and transforming growth factor-beta in normal and transformed glia in vitro.

Authors:  T C Ryken; V C Traynelis; R Lim
Journal:  J Neurosurg       Date:  1992-05       Impact factor: 5.115

8.  Transforming growth factor-beta-like activity in tumors of the central nervous system.

Authors:  W C Clark; J Bressler
Journal:  J Neurosurg       Date:  1988-06       Impact factor: 5.115

9.  The effect of type beta transforming growth factor on proliferation of clonogenic cells from human gliomas.

Authors:  E Helseth; G Unsgaard; A Dalen; R Vik
Journal:  Acta Neurochir Suppl (Wien)       Date:  1988

10.  Epidermal growth factor receptors in the human glioblastoma cell line SF268 differ from those in epidermoid carcinoma cell line A431.

Authors:  M Westphal; G R Harsh; M L Rosenblum; R G Hammonds
Journal:  Biochem Biophys Res Commun       Date:  1985-10-15       Impact factor: 3.575

View more
  5 in total

1.  Plasma platelet-derived growth factor-B chain is elevated in patients with extensively large brain tumour.

Authors:  M Kurimoto; M Nishijima; Y Hirashima; S Endo; A Takaku
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

Review 2.  Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis.

Authors:  Balveen Kaur; Fatima W Khwaja; Eric A Severson; Shannon L Matheny; Daniel J Brat; Erwin G Van Meir
Journal:  Neuro Oncol       Date:  2005-04       Impact factor: 12.300

3.  Tissue factor and cancer procoagulant expressed by glioma cells participate in their thrombin-mediated proliferation.

Authors:  T Ogiichi; Y Hirashima; S Nakamura; S Endo; M Kurimoto; A Takaku
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

4.  Modulation of tissue-type plasminogen activator expression by platelet activating factor in human glioma cells.

Authors:  Takuya Akai; Kenji Niiya; Nobuo Sakuragawa; Hideaki Iizuka; Shunro Endo
Journal:  J Neurooncol       Date:  2002-09       Impact factor: 4.130

5.  Interaction of transforming growth factor-beta (TGF-beta) and epidermal growth factor (EGF) in human glioma cells.

Authors:  Janka Held-Feindt; Björn Lütjohann; Hendrik Ungefroren; Hubertus M Mehdorn; Rolf Mentlein
Journal:  J Neurooncol       Date:  2003-06       Impact factor: 4.130

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.